Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.64B
Enterprise Value4.72B
P/E Ratio65.76
PEG Ratio0.67
Price/Sales Ratio2.27
Price/Book Ratio2.49
Enterprise/Revenue2.8
Enterprise/EBITDA27.27

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue1.76B
Revenue/Share3.23
Gross Profit492.23M
EBITDA199.48M
Net Income60M
Diluted EPS0.11

Balance Sheet

Total Cash181.53M
Total Cash/Share0.33
Total Debt1.13B
Total Debt/Equity0.7
Current Ratio1.26
Book Value Per Share3.01

Price History

52-Week Change15.13
52-Week High9.44
52-Week Low5.99
Moving Average 50 Days7.63
Moving Average 200 Days7.17

Statistics

Average Volume26.52M
Shares Outstanding559.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.01
Trailing Annual Dividend Yield0.19
Payout Ratio0.79
Last Split Factor13:10
Last Split DateMay 12, 2010
AD